Management of community-acquired acute bacterial cystitis in Turkey

Community acquired acute bacterial cystitis (CA-ABC) is one of the most common infectious presentations in the community. This paper aims to provide a rational approach in the management of CA-ABC based on local Turkish data. Materials and methods: The publications evaluating the microbiological data obtained from CA-ABC cases were searched in both Turkish and international databases. Results: Fosfomycin and nitrofurantain appear to be baseline antibiotics while the empirical use of trimethoprim sulfamethoxazole, amoxicillin clavulanate, and first and second generation cephalosporins seems to be unreliable in Turkey. Moreover, quinolones seem to be at the edge with resistance rates up to 20%. On the other hand, aminoglicosides, third and fourth generation cephalosporins, and piperacillin-tazobactam look more trustworthy. Conclusion: According to local Turkish data, caution is really indicated in rational antibiotic use in the community since the traditional drugs used in the management of CA-ABC are being lost steadily.

Anahtar Kelimeler:

Key words: Community-acquired, urinary, infection, Turkey

Management of community-acquired acute bacterial cystitis in Turkey

Keywords:

Key words: Community-acquired, urinary, infection, Turkey,

PDF

___

Alam MF, Cohen D, Butler C, Dunstan F, Roberts Z, Hillier S et al. The additional costs of antibiotics and re-consultations for antibiotic-resistant Escherichia coli urinary tract infections managed in general practice. Int J Antimicrob Agents, 2008; 15:(Epub ahead of print).
Sobel JD, Kaye D. Urinary Tract Infections. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. 6 ed: Churchill Livingstone 2005: 875-904.
McCarty JM, Richard G, Huck W, Tucker RM, Tosiello RL, Shan M et al. A randomized trial of short-course ciprofloxacin, ofloxacin, or trimethoprim/sulfamethoxazole for the treatment of acute urinary tract infection in women. Ciprofloxacin Urinary Tract Infection Group. The American Journal of Medicine, 1999; 106: 292-9.
Nicolle L, Anderson PA, Conly J, Mainprize TC, Meuser J, Nickel JC et al. Uncomplicated urinary tract infection in women. Current practice and the effect of antibiotic resistance on empiric treatment. Can Fam Physicia,. 2006; 52: 612-8.
McQuilkin M, Lund A, Palmer W. Antimicrobial resistance of uncomplicated urinary tract infections in northern Utah. Clin Lab Sci, 2008; 21: 99-101.
Schaeffer AJ. The expanding role of fluoroquinolones. Am J Med, 2002; 113: 45-54.
Biswas D, Gupta P, Prasad R, Singh V, Arya M, Kumar A. Choice of antibiotic for empirical therapy of acute cystitis in a setting of high antimicrobial resistance. Indian J Med Sci, 2006; 60: 53-8.
Goldstein FW. Antibiotic susceptibility of bacterial strains isolated from patients with community-acquired urinary tract infections in France. Multicentre Study Group. Eur J Clin Microbiol Infect Dis, 2000; 19: 112-7. 18. Tankhiwale
SS, Jalgaonkar SV, Ahamad S, Hassani U. Evaluation
of extended spectrum beta lactamase in urinary isolates. Indian
J Med Res, 2004; 120: 553-56.
Amsden GW. Tables of antimicroal agent pharmacology. In: Mandel GL BJDR, ed. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Philadelphia: Churchill Livingstone, 2000: 551-603.
Gagliotti C, Buttazzi R, Sforza S, Moro ML. Resistance to fluoroquinolones and treatment failure/short-term relapse of community-acquired urinary tract infections caused by Escherichia coli, J Infect. 2008; 57: 179-84.
Baykan M, Kaya M, Arslan U, Baysal B. İdrar örneklerinden izole edilen E.coli suşlarının antimikrobiyallere duyarlılıklarının değerlendirilmesi (The evaluation of antibiotic susceptibility patterns of E.coli strains isolated from urine specimens). İnönü Üniv Tıp Fak Derg, 2001; 8: 15-7. (in Turkish).
Taşbakan MI, Pullukçu H, Yamazhan T, Arda B, Ulusoy S. Toplum kökenli üriner sistem infeksiyonlarından soyutlanan Escherichıa coli suşlarına fosfomisinin in-vitro etkinliğinin diğer antibiyotiklerle karşılaştırılması (The comparison of fosfomycin with other antimicrobials in Escherichia coli strains isolated from community acquired UTIs). ANKEM Derg, 2004; 18: 216-19. (in Turkish).
Rafal'skii VV, Rokhlikov IM, Strachunskii LS. Clinicomicrobiological characteristics of community-acquired infections of the urinary tracts in Moscow. Urologia, 2007; 18: 20-3.
Gobernado M, Valdes L, Alos JI, Garcia-Rey C, Dal-Re R, Garcia-de-Lomas J. Quinolone resistance in female outpatient urinary tract isolates of Escherichia coli: age-related differences. Rev Esp Quimioter, 2007; 20: 206-10.
Hima-Lerible H, Menard D, Talarmin A. Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in Bangui, Central African Republic. J Antimicrob Chemother, 2003; 51: 192-4.
Randrianirina F, Soares JL, Carod JF, Ratsima E, Thonnier V, Combe P, et al. Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in Antananarivo, Madagascar. J Antimicrob Chemother, 2007; 59: 309-12.
Fu Y, Zhang F, Zhang W, Chen X, Zhao Y, Ma J et al. Differential expression of bla(SHV) related to susceptibility to ampicillin in Klebsiella pneumoniae. International journal of antimicrobial agents, 2007; 29: 344-7.
Perez F, Endimiani A, Hujer KM, Bonomo RA. The continuing challenge of ESBLs. Curr Opin Pharmacol, 2007; 7: 459-69.
Yilmaz E, Akalin H, Ozbey S, Kordan Y, Sinirtas M, Gurcuoglu E et al. Risk factors in community-acquired/onset urinary tract infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae. J Chemother, 2008; 20: 581-5.
Rodriguez-Bano J, Alcala JC, Cisneros JM, Grill F, Oliver A, Horcajada JP et al. Community infections caused by extended- spectrum beta-lactamase-producing Escherichia coli. Arch Intern Med, 2008; 168: 1897-902. Gupta K, Stamm WE. Outcomes associated with trimethoprim/sulphamethoxazole (TMP/SMX) therapy in TMP/SMX resistant community-acquired UTI. International journal of antimicrobial agents, 2002; 19: 554-6.
Vidal L, Gafter-Gvili A, Borok S, Fraser A, Leibovici L, Paul M. Efficacy and safety of aminoglycoside monotherapy: systematic review and meta-analysis of randomized controlled trials. J Antimicrob Chemother, 2007; 60: 247-57.
eckentdorf HK, Castringius RG, Spingler HK. Comparative pharmacodynamics, urinary excretion, and half-life determinations of nitrofurantoin sodium. Antimicrob Agents Chemother, 1962; 2: 531-37.
Hooton TM, Winter C, Tiu F, Stamm WE. Randomized comparative trial and cost analysis of 3-day antimicrobial regimens for treatment of acute cystitis in women. JAMA, 1995; 273: 41-5.
Fekete T. 5 days of nitrofurantoin was equivalent to 3 days of trimethoprim-sulfamethoxazole for women with non- complicated cystitis. Evid Based Med, 2008; 13: 80.
Knottnerus BJ, Nys S, Ter Riet G, Donker G, Geerlings SE, Stobberingh E. Fosfomycin tromethamine as second agent for the treatment of acute, uncomplicated urinary tract infections in adult female patients in The Netherlands? J Antimicrob Chemother, 2008; 62: 356-9.
Patel SS, Balfour JA, Bryson HM. Fosfomycin tromethamine. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy as a single-dose oral treatment for acute uncomplicated lower urinary tract infections. Drugs, 1997; 53: 637-56.
Pullukcu H, Tasbakan M, Sipahi OR, Yamazhan T, Aydemir S, Ulusoy S. Fosfomycin in the treatment of extended spectrum beta-lactamase-producing Escherichia coli-related lower urinary tract infections. Int J Antimicrob Agents, 2007; 29: 62- 5.
Bozkurt ÖF, Kara C, Akarsu S, Çağlar M, Ünsal A. Semptomatik idrar yolu enfeksiyonu olan kadinlarin tedavisinde tek doz fosfomisin etkinliğinin siprofloksasin ile karşilaştirilması (The comparison of ciprofloxacin and single dose fosfomycin in the management of symptomatic urinary tract infections in women). Türk Urol Derg, 2008; 34: 360-62. (in Turkish).
Hooton TM, Stamm WE. Diagnosis and treatment of uncomplicated urinary tract infection. Infect Dis Clin North Am, 1997; 11: 551-81.
Altoparlak Ü, Özek A, Aktaş F. Üriner sistem infeksiyonlarından izole edilen bakterilerin çeşitli antibiyotiklere duyarlılıkları (The antibiotic susceptibility patterns of bacteria isolated from urinary tract infections). Türk Mikrobiyol Cem Derg, 2001; 32: 167-73. (in Turkish).
Timurkaynak F, İnci KE, Arslan H. Toplum kökenli ve nozokomiyal üriner sistem infeksiyonlarından izole edilen etkenlerin dağılımı ve antibiyotik duyarlılığı (The distribution of agents and their antibiotic susceptibilities in community acquired and nosocomial UTIs). Ankara Üniv Tıp Fak Mec, 2001; 54: 287-92. (in Turkish).
Savaş L, Güvel S, Turunç T, Savaş N, Arslan H. Toplum kökenli ve nazokomiyal üriner sistem enfeksiyon etkenleri ve antibiyotik duyarlılıklarının karşılaştırılması (The causative agents isolated from community acquired and nosocomial UTIs and comparison of their antibiotic susceptibilities). Türk Üroloji Dergisi, 2003;29: 95-100. (in Turkish).
Arslan H, Azap ÖK, Ergönül Ö, Timurkaynak F Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey. Journal of Antimicrobial Chemotherapy, 2005; 56: 914-18.
Akay H, Durunay M, Akay A. Üriner sistem enfeksiyonlarından izole edilen mikroorganizmaların dağılımı ve Escherichia coli suşlarında antibiyotik duyarlılığı (The distribution and susceptibility patterns of microorganisms isolated from urinary tract infections). J Ist Faculty Med, 2006; 69: 1-4. (in Turkish).
Çetin M, Ocak S, Görür S, Avunduk G. Semtomatik üriner sistem enfeksiyonlarında üropatojenler ve izole edilen Escherichia coli suşlarının antibiyotik duyarlılığı (The uropathogens in symptomatic UTIs and the antibiotic susceptibility of the Escherichia coli strains). ANKEM Derg, 2006; 20: 169-72. (in Turkish).
Pullukçu H, Taşbakan MI, Aydemir Ş, Sipahi OR, Turhan A, Özinel MA, Ulusoy S. İdrar kültürlerinde soyutlanan bakteriler ve çeşitli antibiyotiklere invitro duyarlılıklarının değerlendirilmesi (The bacteria isolated from urine cultures and investigation of their susceptibilities to various antibiotics). ANKEM Derg, 2006; 20: 26-30.
Akan ÖA. İbn-i Sina hastanesinde poliklinik idrar örneklerinden izole edilen Escherıchıa coli izolatlarının ilk seçenek antibiyotiklere direnç durumu (The resistance of E.coli strains isolated from outpatients in Ibn-i Sina Hospital). Ankara Üniv Tıp Fak Mecm, 2003; 56: 147-50. (in Turkish).
Dündar D, Topçu AW, Tamer GS. İdrar yolu infeksiyonu etkenleri ve antimikrobiyal duyarliliklari (The agents of UTIs and their antibiotic susceptibilities). Klimik Dergisi, 2008; 21: 7- 11 (in Turkish).
Ay S, İşeri LA, Duman B. İdrar örneklerinden izole edilen gram olumsuz mikroorganizmaların antibiyotiklere duyarlılıkları (The antibiotic susceptibility of gram-negatives isolated from urine specimens). İnönü Üniversitesi Tıp Fakültesi Dergisi, 2003; 10: 59-62. (in Turkish).
Sümer Z, Coşkunkan F, Vahapoğlu H, Bakır M. The resistance of Escherichia coli strains isolated from community-acquired urinary tract infections. Advances in Therapy, 2005; 22 : 419- 23.
Yuluğkural Z, Mutlu B. İdrar kültürlerinden izole edilen Escherichia coli suşlarının sık kullanılan antibakteriyellere karşı duyarlılıkları (The susceptibilities of Escherichia coli strains isolated from UTIs to commonly used antibiotics). Trakya Univ Tıp Fak Derg, 2007; 24: 6-11. (in Turkish).
Erdem H, Kilic S, Pahsa A, Besirbellioglu BA. Gram negative bacterial resistance to gram negative bacteria for cephalosporins in community acquired infections in Turkey. J Chemother, 2005; 17: 61-5.
Akçam ZF, Kaya O, Gönen İ, Yaylı G. İdrar Örneklerinden Izole Edilen Toplum ve Hastane Kaynaklı Escherichia coli suşlarında Antibiyotik Direnci (The antibiotic resistance of Escherichia coli strains isolated from nosocomial and community acquired infections). OMU Tıp Dergisi, 2004; 21: 23-7. (in Turkish).
Erdem H, Avcı A, Pahsa A. Toplum kaynaklı üropatojenik Escherichia coli suşlarında antibakteriyel direnç (The antibiotic resistance in community acquired uropathogenic Escherichia coli strains). ANKEM Derg, 2004; 18: 40-4. (in Turkish).
Karaca Y, Coplu N, Gozalan A, Oncul O, Citil BE, Esen B Co- trimoxazole and quinolone resistance in Escherichia coli isolated from urinary tract infections over the last 10 years. Int J Antimicrob Agents, 2005; 26: 75-7.
Eroğlu M, Koçoğlu E, Karabay O, Semerciöz A. Toplum kaynaklı erişkin üriner sistem enfeksiyonlarından izole edilen Enterobacteriacea türlerinin bazı antibiyotiklere duyarlılıkları (The susceptibility of Enterobacteriacea species isolated from community acquired adult UTIs to various antibiotics). Türk Üroloji Dergisi, 2007; 33: 100-3. (in Turkish).
Ertuğrul MB, Çolak N İdrardan izole edilen toplum kökenli Escherichia coli suşlarının antibiyotik duyarlılıkları (The antibiotic susceptibilities of community-acquired urinary E. coli isolates). ANKEM Derg, 2004 ;18: 161-5. (in Turkish).
Ertuğrul MB, Güleç LA, Akal D, Çağatay AA, Özsüt H, Eraksoy H. Üropatojen Escherichia coli suşlarının tedavide sık kullanılan antibiyotiklere duyarlılıkları (The susceptibilities of uropathogenic E. coli strains to frequently used antibiotics). Klimik Derg. 2004; 17: 132-6. (in Turkish).
Kurutepe S, Surucuoglu S, Sezgin C, Gazi H, Gulay M, Ozbakkaloglu B. Increasing antimicrobial resistance in Escherichia coli isolates from community-acquired urinary tract infections during 1998-2003 in Manisa, Turkey. Jpn J Infect Dis, 2005; 58: 159-6.
Sucu N, Boz GA, Bayraktar Ö, Çaylan R, Aydın K, Köksal İ. Üropatojen Escherichia coli suşlarının antibiyotik duyarlılıklarının yıllar içerisindeki değişimi (The changes in antibiotic susceptibilities in uropathogen Escherichia coli strains). Klimik Derg. 2004; 17: 128-31. (in Turkish).
Şencan İ, Sevinç ME. Toplum Kökenli Üropatojen Escherichia coli izolatlarında antimikrobiyal direncin izlemi (The follow up of antibiotic resistance in community acquired Escherichia coli isolates). Klimik Derg, 2002; 15: 85-8. (in Turkish).
Bayraktar B, Özcan N, Borahan S, Başarı F, Bulut E. Yatan ve ayaktan hastalardan izole edilen üriner sistem enfeksiyonu etkeni gram negatif çomaklarda antibiyotiklere direnç (The antibiotic resistance of gram negatives obtained from urinary tract infections in inpatients and outpatients). ANKEM Derg, 2004; 18: 137-40. (in Turkish).
Otağ F, Yıldız Ç, Delialioğlu N. İdrardan soyutlanan Escherichia coli suşlarında antibiyotik direnci (The antibiotic resistance in Escherichia coli strains isolated from urine). ANKEM Derg, 2003; 17: 284-7. (in Turkish). 65. Ozyurt
M, Haznedaroglu T, Sahiner F, Oncul O, Ceylan S, Ardic
N et al. Antimicrobial resistance profiles of community
acquired uropathogenic Escherichia coli isolates during 2004
in a training hospital in Istanbul. Mikrobiyol Bul. 2008; 42: 231-43.
Köken G, Aşık G, Çifçi İH, Çetinkaya Z, Aktepe OC, Yılmazer M. Toplum kökenli üriner sistem infeksiyonu etkeni E.coli suşlarında fosfomisin trometamol etkinliği (The efficacy of fosfomycin trometamol in community acquired E.coli strains. ANKEM Derg, 2008; 22: 23-7. (in Turkish).
Afşar İ, Gönül B, Şener AG, Türker M. In-vitro susceptibility of clinical isolates of Escherichia coli to fosfamycin trometamol and other antibiotics. ANKEM Derg. 2005; 19: 77-9. (in Turkish).
Okaygün E, Kipritçi Ö, Akman A, Aydın D. Toplum ve hastane kaynaklı üriner sistem enfeksiyonlarında etken mikroorganizmalar ve antibiyotik direnci (The causative pathogens and their antibiotic susceptibilities in community acquired and nosocomial UTIs). ANKEM kongresi Antalya, 2006. (in Turkish).
Koçoğlu E, Karabay O, İnce NK, Özkardeş F, Yıldırım R. Toplum kaynaklı üriner sistem enfeksiyonlarından izole edilen E. coli izolatlarından genişletilmiş spektrumlu beta laktamaz ve bazı antibiyotiklere direnç sıklığının araştırılması (The investigation of ESBL production and resistance profiles to various antibiotics in E.coli strains isolated form community acquired UTIs). ANKEM Derg, 2007; 21: 5-9. (in Turkish).
Bayraktar B, Özcan N, Borahan S, Başarı F, Bulut E. Yatan ve ayaktan hastalardan izole edilen üriner sistem enfeksiyonu etkeni gram negatif çomaklarda antibiyotiklere direnç. ANKEM Derg, 2004; 18: 137-40.